In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
The new triazole derivative SCH 56592 has been tested in a National Committee for Clinical Laboratory Standards-adapted in vitro susceptibility test, and its activity against 12 isolates of Blastomyces dermatitidis yeast-like forms has been compared with those of amphotericin B, itraconazole, and fl...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1996
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163319/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723494/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1314 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|